Quick Answer
Outset Medical, Inc. reported Operating Income Loss of -$66.71 million for the year ending 2025.
- Outset Medical, Inc. showed an increase of +41.2% in Operating Income Loss from 2024 to 2025.
- This data is from Outset Medical, Inc.'s annual report (Form 10-K), filed with the SEC on February 13, 2026.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2019: -$18.45 million | Q1 2020: -$20.21 million | Q2 2020: -$24.91 million | Q3 2020: -$40.73 million | Q1 2021: -$29.68 million | Q2 2021: -$29.91 million | Q3 2021: -$30.14 million | Q1 2022: -$36.48 million | Q2 2022: -$43.72 million | Q3 2022: -$41.00 million | Q1 2023: -$43.49 million | Q2 2023: -$43.48 million | Q3 2023: -$45.45 million | Q1 2024: -$36.91 million | Q2 2024: -$30.76 million | Q3 2024: -$23.84 million | Q1 2025: -$16.40 million | Q2 2025: -$16.87 million | Q3 2025: -$15.81 million.
- Over the full 8 years of available data (2018 to 2025), Outset Medical, Inc.'s Operating Income Loss has declined by 43.3%.
- Historical annual values: Fiscal year 2025: -$66.71 million | Fiscal year 2024: -$113.38 million | Fiscal year 2023: -$169.77 million | Fiscal year 2022: -$161.02 million | Fiscal year 2021: -$130.52 million | Fiscal year 2020: -$117.47 million | Fiscal year 2019: -$70.31 million | Fiscal year 2018: -$46.56 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: